|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pathophysiology of sepsis显示文摘 | REMICK D G | 2007 | Am J Pathol2007，170，5： | 1 |
| 2 | Role of interleukin-6 in mortality from and physiologic response to sepsis显示文摘 | Remick D G Bolgos G Copeland S | 2005 | Infect Immun2005，73，： | 1 |
| 3 | Phase II trial of doeetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxie chemotherapy: The Eastern Cooperative Oncology Group (ECOG) results of protocol E1293 显示文摘 | Einzig AI Neuberg D Remick SC | 1996 | Med Oncol1996，13，： | 1 |
| 4 | Model of angiogenesis in mice with severe combined immunodeficiency (SCID)and xenoengrafted with Epstein-Barr virus transformed B cells显示文摘 | Call D R Remick D g | 2004 | Comp Med2004，54，2： | 1 |
| 5 | Pathophysiology of sepsis显示文摘 | REMICK D G | 2007 | AmJ Pathol2007，170，： | 1 |
| 6 | Pathophysiology of sepsis显示文摘 | Remick D G | 2007 | Am J Pathol2007，170，5： | 1 |
| 7 | Acute pancreatitis:models,markers,and mediators显示文摘 | Granger J Remick D | 2005 | Shock2005，24，1： | 1 |
| 8 | Sepsis:redox mechanisms and therapeutic opportunities显示文摘 | Biswal S Remick D G | | 0，，11： | 1 |
| 9 | Acute pancreatitis: models, markers, and mediators显示文摘 | Granger J Remick D | 2005 | Shock2005，24，1： | 1 |
| 10 | Acute pancreatitis : models, markers, and mediators显示文摘 | Granger J Remick D | 2005 | Shock2005，24，1： | 1 |
| 11 | Endotoxin, sepsis, and the primrose path 显示文摘 | O'Reilly M Newcomb DE Remick D | 1999 | Shock1999，12，6： | 1 |
| 12 | Endotoxin, sepsis, and the primrose path显示文摘 | Reily M Newcomb D E Remick D | 1999 | Shock1999，12，6： | 1 |
| 13 | Comparison of the mortality and inflammatory response of two models of sepsis:lipopolysaccharide vs cecal ligation and puncture显示文摘 | Remick D G Newcomb D E Bolgos G | 2000 | Shock2000，13，： | 1 |
| 14 | Role of interleukin-6 in mortality from and physiologic response to sepsis 显示文摘 | Remick D G Bolgos G Copeland S | 2005 | Infect Immun2005，73，5： | 1 |
| 15 | Acute pancreatitis models markers and mediaters 显示文摘 | Granger J Remick D | 2005 | Shock2005，24，1： | 1 |
| 16 | A dose-escalating and pharmacologic study of bortezomib in adult cancer patients with impaired renal function 显示文摘 | Mulkerin D Remick S Ramanathan R | 2006 | J Clin Oncol2006，24，18： | 1 |
| 17 | Block of tumor necrosis factor reduces lipopolysaccharide lethality,but not the lethality of cecal ligation and puncture显示文摘 | Remick D G Manohar P Bolgos G | 1995 | Shock1995，4，： | 1 |
| 18 | Endotoxin,sepsis,and the primarily path显示文摘 | Newcomb DE Remick D | 1999 | Shock1999，12，6： | 1 |
| 19 | Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy:the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293显示文摘 | Einzig AI Neuberg D Remick SC | 1996 | Med Oncol1996，13，2： | 1 |
| 20 | Inhibition of Kupffer cells reduced CXC chemokine production and liver injury显示文摘 | Mosher B Dean R Harkema J Remick D Palma J Crockett E | 2001 | J Surg Res2001，99，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员